Suppr超能文献

间变性淋巴瘤激酶阳性大B细胞淋巴瘤:文献综述及1例具有模仿精原细胞瘤的虎斑样背景的内镜下细针穿刺病例报告

Anaplastic lymphoma kinase positive large B-cell lymphoma: Literature review and report of an endoscopic fine needle aspiration case with tigroid backgrounds mimicking seminoma.

作者信息

Sakr Hany, Cruise Michael, Chahal Prabhleen, Cotta Claudiu, Cook James, Chalikonda Sricharan, Rosenblatt Steven, Hamadeh Fatima, Al-Nourhji Omar, Sturgis Charles D

机构信息

Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio.

Department of Gastroenterology, Cleveland Clinic, Cleveland, Ohio.

出版信息

Diagn Cytopathol. 2017 Feb;45(2):148-155. doi: 10.1002/dc.23616. Epub 2016 Sep 30.

Abstract

Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK+ LBCL) is a rare distinct type of non-Hodgkin's lymphoma that arises in association with alterations of the ALK gene. This distinct disease entity is typically associated with an aggressive clinical course and appears in light microscopic preparations as a monomorphic population of large, immunoblast-like cells. In this report, we describe a case of ALK+ LBCL diagnosed by transgastric endoscopic ultrasound-guided fine needle aspiration (EUS FNA) of splenic hilar lymph nodes. Modified Giemsa stained direct smears from the FNA sample demonstrated large lesional cells with foamy cytoplasm and macronucleoli admixed with small lymphocytes in tigroid backgrounds, mimicking the cytologic appearance of seminoma. Ancillary immunohistochemical studies subsequently confirmed the diagnosis of ALK+ LBCL with the lesional cells being immunoreactive for CD138, VS38c, MUM1, ALK1, and lambda light chain. The cohesiveness of the cells, the cellular morphology, and the tigroid backgrounds were all pitfalls for accurate diagnosis of this rare specific type of lymphoid malignancy by cytology. To our knowledge this is the first case report detailing the diagnosis of ALK+ LBCL by EUS FNA and the first report describing a glycogen-rich tigroid background in direct FNA smears. Establishing a refined diagnosis in cases of this rare form of LBCL is necessary, as therapies targeting ALK may be of value in clinical management. Diagn. Cytopathol. 2017;45:148-155. © 2016 Wiley Periodicals, Inc.

摘要

间变性淋巴瘤激酶阳性大B细胞淋巴瘤(ALK+ LBCL)是一种罕见的非霍奇金淋巴瘤,与ALK基因改变有关。这种独特的疾病实体通常与侵袭性临床病程相关,在光学显微镜下表现为一大群形态单一的、大的免疫母细胞样细胞。在本报告中,我们描述了一例通过经胃内镜超声引导下细针穿刺活检(EUS FNA)脾脏门淋巴结诊断为ALK+ LBCL的病例。FNA样本改良吉姆萨染色直接涂片显示,在虎斑样背景中,病变大细胞具有泡沫状细胞质和大核仁,并混有小淋巴细胞,类似精原细胞瘤的细胞学表现。随后的辅助免疫组化研究证实了ALK+ LBCL的诊断,病变细胞对CD138、VS38c、MUM1、ALK1和λ轻链呈免疫反应性。细胞的黏附性、细胞形态和虎斑样背景都是通过细胞学准确诊断这种罕见的特定类型淋巴恶性肿瘤的陷阱。据我们所知,这是第一例详细描述通过EUS FNA诊断ALK+ LBCL的病例报告,也是第一例描述直接FNA涂片中有富含糖原的虎斑样背景的报告。对于这种罕见形式的LBCL病例进行精确诊断是必要的,因为针对ALK的治疗在临床管理中可能具有价值。诊断细胞病理学。2017年;45:148 - 155。© 2016威利期刊公司

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验